Michael H. Brave
- Oncology top 10%
- Hematology top 5%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Genetics top 10%
- Co-authors
- Richard PazdurRajeshwari SridharaAmna IbrahimShenghui TangRobert JusticeBrian BoothV. Ellen MaherJulia A. Beaver
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Bladder and Urothelial Cancer Treatments (5 papers)Cancer Genomics and Diagnostics (3 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United States
In The Last Decade
Michael H. Brave
15 papers receiving 654 citations
Peers
Comparison fields: 5 of 61
- Oncology 374
- Hematology 178
- Pulmonary and Respiratory Medicine 158
- Molecular Biology 136
- Genetics 126
Countries citing papers authored by Michael H. Brave
This map shows the geographic impact of Michael H. Brave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Brave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Brave more than expected).
Fields of papers citing papers by Michael H. Brave
This network shows the impact of papers produced by Michael H. Brave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Brave. The network helps show where Michael H. Brave may publish in the future.
Co-authorship network of co-authors of Michael H. Brave
This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Brave. A scholar is included among the top collaborators of Michael H. Brave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Brave. Michael H. Brave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 8 | |
| 3 | 12 | |
| 4 | 7 | |
| 5 | 20 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 231 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 35 | |
| 13 | 100 | |
| 14 | 190 | |
| 15 | Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer. | 37 |
About Michael H. Brave
Michael H. Brave is a scholar working on Cancer Research, Oncology and Genetics, having authored 15 papers that have together received 664 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hematology (178 citations), Oncology (374 citations) and Genetics (126 citations). Michael H. Brave has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Rajeshwari Sridhara, Amna Ibrahim, Shenghui Tang, Robert Justice, Brian Booth, V. Ellen Maher, Julia A. Beaver, Daniel L. Suzman and Chana Weinstock. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.